{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:24:39Z","timestamp":1794255879441,"version":"4.9.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"This study was sponsored by Eli Lilly and Company, Indianapolis, USA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s12325-026-03736-8","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T09:48:01Z","timestamp":1786614481000},"page":"5305-5326","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Humanistic Burden and Gaps in Care and Treatment Policies of Obesity in Canada: A Systematic Review"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5460-8495","authenticated-orcid":false,"given":"Christine","family":"Longuet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Artime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Kewley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Kuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Patton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C. W.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"3736_CR1","unstructured":"World Obesity Federation. World Obesity Atlas 2023. https:\/\/data.worldobesity.org\/publications\/?cat=19. Accessed 31 Mar 2025."},{"issue":"31","key":"3736_CR2","doi-asserted-by":"publisher","first-page":"E875","DOI":"10.1503\/cmaj.191707","volume":"192","author":"S Wharton","year":"2020","unstructured":"Wharton S, Lau DCW, Vallis M, et al. Obesity in adults: a clinical practice guideline. CMAJ. 2020;192(31):E875\u201391.","journal-title":"CMAJ"},{"issue":"4","key":"3736_CR3","doi-asserted-by":"publisher","first-page":"e1339","DOI":"10.1210\/clinem\/dgab848","volume":"107","author":"WT Garvey","year":"2022","unstructured":"Garvey WT. New horizons. A new paradigm for treating to target with second-generation obesity medications. J Clin Endocrinol Metab. 2022;107(4):e1339\u201347.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3736_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-21905-2","volume":"25","author":"F Chen","year":"2025","unstructured":"Chen F, Sapra T, Natale Z, Dall TM, Patton I, Sockalingam S. Modeling the cost of inaction in treating obesity in Canada. BMC Public Health. 2025;25(1):865. https:\/\/doi.org\/10.1186\/s12889-025-21905-2.","journal-title":"BMC Public Health"},{"issue":"2","key":"3736_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.26444\/aaem\/97226","volume":"26","author":"J Krzysztoszek","year":"2019","unstructured":"Krzysztoszek J, Laudanska-Krzeminska I, Bronikowski M. Assessment of epidemiological obesity among adults in EU countries. Annal Agric Environ Med. 2019;26(2):341\u20139.","journal-title":"Annal Agric Environ Med"},{"issue":"11","key":"3736_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260158","volume":"16","author":"SA Keramat","year":"2009","unstructured":"Keramat SA, Alam K, Rana RH, et al. Obesity and the risk of developing chronic diseases in middle-aged and older adults: findings from an Australian longitudinal population survey, 2009\u20132017. PLoS ONE. 2009;16(11):e0260158.","journal-title":"PLoS ONE"},{"key":"3736_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.metabol.2018.11.001","volume":"92","author":"KI Avgerinos","year":"2019","unstructured":"Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M. Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism. 2019;92:121\u201335.","journal-title":"Metabolism"},{"key":"3736_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ypmed.2018.08.025","volume":"116","author":"M Lebenbaum","year":"2018","unstructured":"Lebenbaum M, Zaric GS, Thind A, Sarma S. Trends in obesity and multimorbidity in Canada. Prev Med. 2018;116:173\u20139.","journal-title":"Prev Med"},{"issue":"10431","key":"3736_CR9","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","volume":"403","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2024","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222\u00a0million children, adolescents, and adults. Lancet. 2024;403(10431):1027\u201350.","journal-title":"Lancet"},{"issue":"11","key":"3736_CR10","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1177\/0956797615601103","volume":"26","author":"AR Sutin","year":"2015","unstructured":"Sutin AR, Stephan Y, Terracciano A. Weight discrimination and risk of mortality. Psych Sci. 2015;26(11):1803\u201311.","journal-title":"Psych Sci"},{"key":"3736_CR11","unstructured":"World Health Organization. Obesity and overweight 2021. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. Accessed 31 Mar 2025."},{"key":"3736_CR12","unstructured":"Zepbound\u2122 KwikPen\u00ae Product Monograph. Eli Lilly Canada, Toronto ON. Revision May\u00a013, 2025."},{"issue":"27","key":"3736_CR13","doi-asserted-by":"publisher","first-page":"E797","DOI":"10.1503\/cmaj.250502","volume":"197","author":"SD Pedersen","year":"2025","unstructured":"Pedersen SD, Manjoo P, Dash S, Jain A, Pearce N, Poddar M. Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update. CMAJ. 2025;197(27):E797\u2013809.","journal-title":"CMAJ"},{"key":"3736_CR14","unstructured":"CADTH Reimbursement Recommendation Semaglutide (Wegovy) May\u00a02025. https:\/\/www.cda-amc.ca\/sites\/default\/files\/DRR\/2025\/SR0841-Wegovy%20Resubmission_DRAFT_Rec.pdf. Accessed 28 May\u00a02025."},{"key":"3736_CR15","unstructured":"Mapol Drug Benefit Communiqu\u00e9\u00ae. Anti-obesity drug coverage: the changing private payer landscape. https:\/\/analytics.mapol.ca\/drug-benefit-communique\/90. Accessed 28 May\u00a02025."},{"key":"3736_CR16","unstructured":"GLP-1 Drugs (Canada). 2025 pulse survey. https:\/\/www.ifebp.org\/resources---news\/survey-reports\/glp-1-drugs-canada--2025-pulse-survey. Accessed 28 May\u00a02025."},{"key":"3736_CR17","unstructured":"Pedersen SD, Manjoo P, Wharton S. Canadian adult obesity clinical practice guidelines: pharmacotherapy for obesity management. 2022. https:\/\/obesitycanada.ca\/guidelines\/pharmacotherapy Accessed 31 Mar 2025."},{"issue":"2","key":"3736_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s13679-018-0309-8","volume":"7","author":"AM Sharma","year":"2018","unstructured":"Sharma AM, Ramos Salas X. Obesity prevention and management strategies in Canada: shifting paradigms and putting people first. Curr Obes Rep. 2018;7(2):89\u201396.","journal-title":"Curr Obes Rep"},{"key":"3736_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"9","key":"3736_CR20","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/jech-2018-211497","volume":"73","author":"AJ Romain","year":"2019","unstructured":"Romain AJ, Marleau J, Baillot A. Association between physical multimorbidity, body mass index and mental health\/disorders in a representative sample of people with obesity. J Epidemiol Commun Health. 2019;73(9):874\u201380.","journal-title":"J Epidemiol Commun Health"},{"key":"3736_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadr.2023.100661","volume":"14","author":"J Mattar","year":"2023","unstructured":"Mattar J, Chauvin V, Marleau J, Kavalidou K, Romain AJ. Association between physical multimorbidity and suicidal ideation in young adults with obesity. J Affect Disord Rep. 2023;14:100661. https:\/\/doi.org\/10.1016\/j.jadr.2023.100661.","journal-title":"J Affect Disord Rep"},{"issue":"10","key":"3736_CR22","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/s41366-018-0209-8","volume":"43","author":"P Stahel","year":"2019","unstructured":"Stahel P, Sud SK, Lee SJ, et al. Phenotypic and genetic analysis of an adult cohort with extreme obesity. Int J Obes. 2019;43(10):2057\u201365.","journal-title":"Int J Obes"},{"key":"3736_CR23","volume":"2023","author":"S English","year":"2020","unstructured":"English S, Vallis M. Moving beyond eat less, move more using willpower: Reframing obesity as a chronic disease. Impact of the 2020 Canadian obesity guidelines reframed narrative on perceptions of self and the patient-provider relationship. Clin Obes. 2020;2023:e12615.","journal-title":"Clin Obes"},{"key":"3736_CR24","unstructured":"Sharma AM. What\u2019s new in the Canadian clinical practice guidelines. European Congress on Obesity (ECO) 2022."},{"key":"3736_CR25","doi-asserted-by":"publisher","first-page":"100089","DOI":"10.1016\/j.obpill.2023.100089","volume":"8","author":"I Patton","year":"2023","unstructured":"Patton I, Salas XR, Hussey B, et al. Patient perceptions about obesity management in the context of concomitant care for other chronic diseases. Obes Pillars. 2023;8:100089. https:\/\/doi.org\/10.1016\/j.obpill.2023.100089.","journal-title":"Obes Pillars"},{"issue":"1","key":"3736_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/osp4.70033","volume":"11","author":"JB Dixon","year":"2025","unstructured":"Dixon JB, Abdul Ghani R, Sbraccia P. Perceptions of obesity among healthcare professionals and policy makers in 2023: results of the global OPEN survey. Obes Sci Pract. 2025;11(1):e70033. https:\/\/doi.org\/10.1002\/osp4.70033.","journal-title":"Obes Sci Pract"},{"issue":"1","key":"3736_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12287","volume":"9","author":"A Bastin","year":"2019","unstructured":"Bastin A, Romain A, Marleau J, Baillot A. Health behaviours, intentions and barriers to change among obesity classes I, II and III. Clinical Obes. 2019;9(1):e12287.","journal-title":"Clinical Obes"},{"issue":"4","key":"3736_CR28","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1111\/dom.15455","volume":"26","author":"DCW Lau","year":"2024","unstructured":"Lau DCW, Patton I, Lavji R, Belloum A, Ng G, Modi R. Obesity management from the perspectives of people living with obesity in Canada: a mixed-methods study. Diabetes Obes Metab. 2024;26(4):1529\u201339.","journal-title":"Diabetes Obes Metab"},{"key":"3736_CR29","doi-asserted-by":"publisher","first-page":"e12701","DOI":"10.1111\/cob.12701","volume":"15","author":"DCW Lau","year":"2024","unstructured":"Lau DCW, Patton I, Lavji R, Belloum A, Ng G, Modi R. Therapeutic inertia in obesity management among people living with obesity from the perspective of general\/family practitioners in Canada: a mixed-methods study. Clin Obes. 2024;15:e12701.","journal-title":"Clin Obes"},{"issue":"4","key":"3736_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/0844562118769229","volume":"50","author":"S Aboueid","year":"2018","unstructured":"Aboueid S, Jasinska M, Bourgeault I, Giroux I. Current weight management approaches used by primary care providers in six multidisciplinary healthcare settings in Ontario. Can J Nurs Res. 2018;50(4):169\u201378.","journal-title":"Can J Nurs Res"},{"issue":"1","key":"3736_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12875-018-0760-3","volume":"19","author":"S Aboueid","year":"2018","unstructured":"Aboueid S, Bourgeault I, Giroux I. Nutrition care practices of primary care providers for weight management in multidisciplinary primary care settings in Ontario, Canada-a qualitative study. BMC Fam Pract. 2018;19(1):1\u20139.","journal-title":"BMC Fam Pract"},{"key":"3736_CR32","unstructured":"Brown J. 2022 Updates of medical nutrition therapy in adult obesity management. Canadian Obesity Summit 2023."},{"key":"3736_CR33","unstructured":"Glass J, Longuet C, Artime E, et al. Real-world weight loss patterns and challenges among people living with obesity in Canada. Canadian Obesity Summit 2023."},{"key":"3736_CR34","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.pmedr.2018.04.003","volume":"10","author":"S Aboueid","year":"2018","unstructured":"Aboueid S, Bourgeault I, Giroux I. Nutrition and obesity care in multidisciplinary primary care settings in Ontario, Canada: short duration of visits and complex health problems perceived as barriers. Prev Med Rep. 2018;10:242\u20137.","journal-title":"Prev Med Rep"},{"issue":"1","key":"3736_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12875-020-01356-x","volume":"22","author":"B Zevin","year":"2021","unstructured":"Zevin B, Martin M, Dalgarno N, et al. Survey of perceptions and educational needs of primary care providers regarding management of patients with class II and III obesity in Ontario, Canada. BMC Fam Pract. 2021;22(1):14.","journal-title":"BMC Fam Pract"},{"issue":"5","key":"3736_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12329","volume":"9","author":"AM Sharma","year":"2019","unstructured":"Sharma AM, B\u00e9langer A, Carson V, et al. Perceptions of barriers to effective obesity management in Canada: results from the ACTION study. Clin Obes. 2019;9(5):e12329.","journal-title":"Clin Obes"},{"issue":"11","key":"3736_CR37","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/oby.23275","volume":"29","author":"RM Puhl","year":"2021","unstructured":"Puhl RM, Lessard LM, Pearl RL, Grupski A, Foster GD. Policies to address weight discrimination and bullying: perspectives of adults engaged in weight management from six nations. Obesity. 2021;29(11):1787\u201398.","journal-title":"Obesity"},{"issue":"2","key":"3736_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41574-022-00777-1","volume":"19","author":"CM Apovian","year":"2023","unstructured":"Apovian CM, Guo X-R, Hawley JA, Karmali S, Loos RJ, Waterlander WE. Approaches to addressing the rise in obesity levels. Nat Rev Endocrinol. 2023;19(2):76\u201381.","journal-title":"Nat Rev Endocrinol"},{"key":"3736_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100636","volume":"31","author":"RL Batterham","year":"2021","unstructured":"Batterham RL. Switching the focus from weight to health: Canada\u2019s adult obesity practice guideline set a new standard for obesity management. EClinicalMedicine. 2021;31:100636.","journal-title":"EClinicalMedicine"},{"key":"3736_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.obpill.2023.100090","volume":"8","author":"X Ramos Salas","year":"2023","unstructured":"Ramos Salas X, Saquimux Contreras MA, et al. Review of an international pilot project to adapt the Canadian adult obesity clinical practice guideline. Obes Pillars. 2023;8:100090.","journal-title":"Obes Pillars"},{"issue":"5","key":"3736_CR41","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.orcp.2024.09.275","volume":"18","author":"P Mirzadeh","year":"2024","unstructured":"Mirzadeh P, Kuk JL, Wharton S, Ardern CI. Overweight and obesity code (E66) trends and predictors in Canada: cross-sectional analysis of discharge abstract data (DAD), 2018-2022. Obes Res Clin Pract. 2024;18(5):322\u20137. https:\/\/doi.org\/10.1016\/j.orcp.2024.09.275.","journal-title":"Obes Res Clin Pract"},{"key":"3736_CR42","doi-asserted-by":"crossref","unstructured":"Aboueid S, Meyer SB, editors. Factors affecting access and use of preventive and weight management care: a public health lens. In: Healthcare management forum. Los Angeles: SAGE; 2019.","DOI":"10.1177\/0840470418824345"},{"issue":"1","key":"3736_CR43","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12916-018-1116-5","volume":"16","author":"AJ Tomiyama","year":"2018","unstructured":"Tomiyama AJ, Carr D, Granberg EM, et al. How and why weight stigma drives the obesity \u201cepidemic\u201d and harms health. BMC Med. 2018;16(1):123.","journal-title":"BMC Med"},{"issue":"4","key":"3736_CR44","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41591-020-0803-x","volume":"26","author":"F Rubino","year":"2020","unstructured":"Rubino F, Puhl RM, Cummings DE, et al. Joint international consensus statement for ending stigma of obesity. Nat Med. 2020;26(4):485\u201397.","journal-title":"Nat Med"},{"key":"3736_CR45","doi-asserted-by":"publisher","DOI":"10.1017\/S1463423619000227","volume":"20","author":"AS Alberga","year":"2019","unstructured":"Alberga AS, Edache IY, Forhan M, Russell-Mayhew S. Weight bias and health care utilization: a scoping review. Prim Health Care Res Dev. 2019;20:e116.","journal-title":"Prim Health Care Res Dev"},{"issue":"11","key":"3736_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048448","volume":"7","author":"JA Sabin","year":"2012","unstructured":"Sabin JA, Marini M, Nosek BA. Implicit and explicit anti-fat bias among a large sample of medical doctors by BMI, race\/ethnicity and gender. PLoS ONE. 2012;7(11):e48448.","journal-title":"PLoS ONE"},{"issue":"3","key":"3736_CR47","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12449","volume":"11","author":"JL Kuk","year":"2021","unstructured":"Kuk JL, Dehlehhosseinzadeh M, Kamran E, Wharton S. An analysis of weight loss efforts and expectations in a Canadian cohort: a retrospective medical chart review. Clin Obes. 2021;11(3):e12449.","journal-title":"Clin Obes"},{"issue":"8","key":"3736_CR48","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/oby.23158","volume":"29","author":"RR Wing","year":"2021","unstructured":"Wing RR. Does lifestyle intervention improve health of adults with overweight\/obesity and type\u00a02 diabetes? Findings from the Look AHEAD randomized trial. Obesity. 2021;29(8):1246\u201358.","journal-title":"Obesity"},{"issue":"2","key":"3736_CR49","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa1212914","volume":"369","author":"RR Wing","year":"2013","unstructured":"Wing RR, Bolin P, Brancati FL, et al. Cardiovascular effects of intensive lifestyle intervention in type\u00a02 diabetes. N Engl J Med. 2013;369(2):145\u201354.","journal-title":"N Engl J Med"},{"issue":"1","key":"3736_CR50","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12325-023-02718-4","volume":"41","author":"N Kotsopoulos","year":"2024","unstructured":"Kotsopoulos N, Connolly MP. Assessing the fiscal burden of obesity in Canada by applying a public economic framework. Adv Ther. 2024;41(1):379\u201390. https:\/\/doi.org\/10.1007\/s12325-023-02718-4.","journal-title":"Adv Ther"},{"key":"3736_CR51","unstructured":"Colley RC, Bushnik T, Barnes J. The health consequences of obesity history and weight fluctuations in adulthood. Health Rep. 2025;36(2):15\u201328."},{"issue":"2","key":"3736_CR52","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12720","volume":"15","author":"S Wharton","year":"2025","unstructured":"Wharton S, Belloum A, Luckevich M, et al. Healthcare utilization associated with obesity management in Ontario, Canada. Clin Obes. 2025;15(2):e12720. https:\/\/doi.org\/10.1111\/cob.12720.","journal-title":"Clin Obes"},{"key":"3736_CR53","unstructured":"Watson H. I'm out here all alone! The challenges and successes of an independent nurse practitioner led obesity medicine clinic. Canadian Obesity Summit 2023."},{"key":"3736_CR54","unstructured":"Poddar M, Macklin D. Evaluating a framework for a national obesity program. Canadian Obesity Summit 2023."},{"key":"3736_CR55","unstructured":"Obesity Canada. Alberta declares March 4 as World Obesity Day, recognizing obesity as a chronic disease. https:\/\/www.globenewswire.com\/news-release\/2025\/03\/04\/3036149\/0\/en\/Alberta-Declares-March-4-as-World-Obesity-Day-Recognizing-Obesity-as-a-Chronic-Disease.html Accessed 31 Mar 2025."},{"key":"3736_CR56","unstructured":"Eggerichs L, Brown J, Goodman B, et al. Obesity treatment and prevention in Canada: an environmental scan of provincial and territorial policies. Canadian Obesity Summit 2023."},{"issue":"2","key":"3736_CR57","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/cob.12131","volume":"6","author":"S Wharton","year":"2016","unstructured":"Wharton S, Serodio KJ, Kuk JL, Sivapalan N, Craik A, Aarts MA. Interest, views and perceived barriers to bariatric surgery in patients with morbid obesity. Clin Obes. 2016;6(2):154\u201360.","journal-title":"Clin Obes"},{"issue":"3","key":"3736_CR58","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejim.2007.09.011","volume":"19","author":"M Mauro","year":"2008","unstructured":"Mauro M, Taylor V, Wharton S, Sharma AM. Barriers to obesity treatment. Eur J Intern Med. 2008;19(3):173\u201380.","journal-title":"Eur J Intern Med"},{"issue":"7","key":"3736_CR59","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/dme.12245","volume":"30","author":"A Nicolucci","year":"2013","unstructured":"Nicolucci A, Burns KK, Holt RIG, et al. Diabetes attitudes, wishes and needs second study (DAWN2\u2122): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabet Med. 2013;30(7):767\u201377.","journal-title":"Diabet Med"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03736-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03736-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03736-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:03:19Z","timestamp":1794254599000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03736-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["3736"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03736-8","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Christine Longuet, Esther Artime, and Jennifer Glass are employees and shareholders of Eli Lilly and Company. Sam Riley and Rachel Kewley were employees of Adelphi Values PROVE at the time this manuscript was prepared; Adelphi Values PROVE received payment from Eli Lilly and Company for the conduct of this systematic review. David C. W. Lau received clinical research trial funding from Amgen, Boehringer Ingelheim, Eli Lilly and Novo Nordisk, and speaker bureau or consulting fees from Amgen, Bayer, Boehringer Ingelheim, CME at Sea, Eli Lilly, HLS Therapeutics, Novartis, Novo Nordisk, Structure Therapeutics, TheraTechnologies, and Zealand Pharma. Ian Patton has no direct competing interests; through Obesity Canada, Ian has been a member of advisory boards and given presentations for Novo Nordisk and Boehringer Ingelheim. Jennifer L. Kuk has nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}